About Actin-like protein 9
Actin-like protein 9 (ACTL9) is a protein
from Homo sapiens identified by UniProt accession
Q8TC94, 416 residues long.
MolForge cross-references it against 0 known binders and
88 disease associations.
Target properties
| Protein name | Actin-like protein 9 |
| UniProt accession | Q8TC94 |
| Gene | ACTL9 |
| Organism | Homo sapiens |
| Length | 416 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (88)
Diseases linked to this target (Open Targets).
- spermatogenic failure 53 · score 0.58
- non-syndromic male infertility due to sperm motility disorder · score 0.37
- late-onset Alzheimers disease · score 0.14
- azoospermia · score 0.10
- male infertility with teratozoospermia due to single gene mutation · score 0.09
- birth weight · score 0.07
- atopic eczema · score 0.07
- partial chromosome Y deletion · score 0.07
- spermatogenic failure 20 · score 0.07
- mosquito bite reaction itch intensity measurement · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TC94-F1 | alphafold | PREDICTED | 87.21 | — |
Amino-acid sequence (416 residues)
MDASRPKSSE SQSSLEAPRP GPNPSPNVVN KPLQRDSPGM VADRLPPKTG AVVIDMGTGT CKVGFAGQAS PTYTVATILG CQPKKPATSG QSGLQTFIGE AARVLPELTL VQPLRSGIVV DWDAAELIWR HLLEHDLRVA THDHPLLFSD PPFSPATNRE KLVEVAFESL RSPAMYVASQ SVLSVYAHGR VSGLVVDTGH GVTYTVPVFQ GYNLLHATER LDLAGNNLTA FLAEMLLQAG LPLGQQDLDL VENIKHHYCY VASDFQKEQA RPEQEYKRTL KLPDGRTVTL GKELFQCPEL LFNPPEVPGL SPVGLSTMAK QSLRKLSLEM RADLAQNVLL CGGSSLFTGF EGRFRAELLR ALPAETHVVV AAQPTRNFSV WIGGSILASL RAFQSCWVLR EQYEEQGPYI VYRKCY
Explore Actin-like protein 9 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets